Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease - Clinical Gastroenterology and Hepatology
Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017–2018 | PLOS ONE
IJMS | Free Full-Text | Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease | HTML
Frontiers | Associations of Uric Acid With Liver Steatosis and Fibrosis Applying Vibration Controlled Transient Elastography in the United States: A Nationwide Cross-Section Study
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD | Nature Reviews Gastroenterology & Hepatology
Methods used for liver evaluation: a) Transient Elastography (TE) and... | Download Scientific Diagram
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect
Diagnostics | Free Full-Text | Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease | HTML
Risk-stratified screening for chronic liver disease using vibration-controlled transient elastography (Fibroscan) | Gastrointestinal Nursing
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine
Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates - ScienceDirect
The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan® - ScienceDirect
Cureus | Accuracy of Ultrasound Elastography and Fibrosis-4 Index (FIB-4) in Ruling Out Cirrhosis in Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients
Untitled Document
Performance characteristics of vibration‐controlled transient elastography for evaluation of nonalcoholic fatty liver disease - Vuppalanchi - 2018 - Hepatology - Wiley Online Library
Measurement of Liver Stiffness and Liver Fat Using Vibration-Controlled Transient Elastography Has Excellent Reproducibility and Intra-Operator Reliability in an Unselected Community-Based Cohort | Internal Medicine Residency Program
Distribution of controlled attenuation parameter (CAP) values in... | Download Scientific Diagram
FibroScan (Vibration-Controlled Transient Elastography): Where Does It Stand in the United States Practice - Clinical Gastroenterology and Hepatology
FibroScan®, transient elastography for liver stiffness - ECHOSENS
Individual patient data meta-analysis of controlled attenuation parameter ( CAP) technology for assessing steatosis - ScienceDirect
Diagnostic of hepatic fibrosis with the XL probe of the Fibroscan versus biopsies in patients candidates to bariatric surgery - Clinical Nutrition ESPEN
Application of transient elastography in nonalcoholic fatty liver disease
Non-Invasive Assessment of Liver Fibrosis by Vibration-Controlled Transient Elastography (Fibroscan®) | IntechOpen
